Abstract
High level of polyamine oxidase activity is detected in sera of depressed as well as in schizophrenic patients. ECT treatment of depressed and schizophrenic patients reduced significantly the level of polyamine oxidase activity in their sera. After ECT treatment, clinically improved depressed and schizophrenic subjects were found to have sera polyamine oxidase activity not significantly differ from that of normal subjects. Possible biochemical mechanisms, which link polyamine oxidase activity, schizophrenia, depression and ECT effect are discussed here.
Similar content being viewed by others
References
Pegg, A. E. and McCann, P. P. 1982. Polyamine metabolism and function. Am. J. Physiol. 243:C212–221.
Pfeiffer, C. C., Iliev, V., Goldstein, L., Jenny, E. H., and Schultz, R. 1970. Blood histamine, Polyamine and the schizophrenia. Res. Comm. Chem. Pathol. Pharmacol. 247–256.
Richardson, A. R. 1985. The side effects of antimalarial drugs indicates a polyamine involvement in both schizophrenic and depression. Medical Hypothesis 18:11–18.
Flayeh, K. A., Saleem, N. M., and Al-Saffar, N. M. 1991. Plasma 1,3 Diamopropane, putrescine and their conjugates in normal and schizophrenic subjects. Arab J. Psychiatry 2:14–21.
Slotkin, T. A. and Bartolome, J. 1986. Role of ornothine decarboxylase and the polyamine in nervous system development. Brain Res. Bull. 17:307–320.
Lau, Ch., Cameron, A., Antolick, L., and Slotkin, T. A. 1990. Trophic control of ornithine decarboxylase/polyamine system in neonatal rat brain regions. Development. Brain Res. 52: 167–173.
Mondovi, B., Riccio, P., and Agostinell, E. 1988. The biological functions of amine oxidase and their reaction products. In: Zappia V., Pegg A. E. (Eds.) Progress in Polyamine Research. New York, Plenum press, pp. 147–161.
Seiler, N., Sarhan, S., Graufel, C., Jones, R., Knodgen, B., and Moulinoux, J. P. 1990. Endogenous and exogenous polyamines in support of tumor growth. Cancer Res. 50:5077–5083.
Flayeh, K. A. and Wallace, H. M. 1991. Polyamine oxidase in human colonic carcinoma cell line. Biochemical soc. Trans. 625:1225.
Morgan, D. M. L. and Illel, G. 1980. Radiochemical estimation of serum polyamines oxidase activity in human pregnancy. Medical Lab. Sci. 38:49.
Kumazawa, T., Suzuki, O., Seno, H., Mizutani, and Matsumoto, T. 1991. Failure to verify high activity of polyamine oxidase in pregnancy serum. Am. J. Obstet. Gynecol. 165:1457–1458.
Flayeh, K. A. 1988. Spermidine oxidase activity in serum of schizophrenic and normal subjects. Clin. Chem. 34:401–403.
Al-Saffar, N. M., Flayeh, K. A., and Ismail, M. K. 1994. Characteristics of spermidine oxidase from sera of schizophrenic and normal subjects. Arab J. Phychiatry. 5:23–30.
Grahame, S. D., Green, A. R., and Costain, D. W. 1978. Mechanism of the antidepressant action of ECT. The Lancet, i:254–257.
Taylor, P. and Fleminger, J. J. 1980. ECT for schizophrenia. Lancet 1:1380–1383.
Cooper, S. J., Leahey, W., Green, D. F., and King, D. J. 1988. The effect of ECT on CSF amino metablites in schizophrenic patients. British J. Psychiatry, 152:59–63.
Scott, A. I. F. 1989. Which depressed patients will respond to ECT. The search for biological predictors of recovery, review article. British J. Psychiatry, 145:8–17.
Dahel, Kh. A. M. 1995. A study of polyamine oxidase in the blood of normal, depressed and schizophrenic subjects. Thesis submitted to the college of science, Mosul University, Mosul, Iraq.
Armitage, P. 1971. Statistical methods in medical research. London, Blackwell Scientific Publications.
Lowry, C. H., Rosebrough, N. J. M., Farr, A. L., and Randall, R. J. 1951. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:265–275.
Fuller, D. J. M., Carper, S. W., Clay, L., Chem, I. R., and Gerner, E. W. 1990. Polyamine regulation of heat-shockinduced spermidine N1-acetylransferase activity. Biochem. J. 267:601–605.
Heby, D. and Persson, L. 1990. Molecular genetics of polyamine synthesis in eukaryotic cells. TIBS 15:153–154.
Munir, M., Subramaniam, S., and McGonigle, P. 1993. Polyamine modulate the neurotoxic effects of NMDA in vivo. Brain Res., 9, 616:163–170.
Murray, R. K. 1996. The biochemical basis of some neuropsychiatric disorders, In: Murray, R. K., Granne, D. K., Mayes, P. A., Rodewell, V. W. eds. Harper Biochemistry. California: Appleton and Lange. pp. 794–813.
De Sarro, G. B., Bagetta, G., Spagnolo, C., and Nistico, G. 1993. Antagonistis of N-methyl-D-aspartate receptors block seizures induced by putrescine in the deep prepiriform cortex. Neuropharmacology 32:43–50.
Wu, L., Mateescu, M. A., Wang, X. T., Mondovi, B., and Wang, R. 1996. Modulation of K+ channel currents by serum amine oxidase in neurons. Biochem. Biophys. Res. Commun. 220: 47–52.
Lopez, H. J., Gorcia, A. E., and Schwartz, S. 1998. Oxidative stress induces age dependent changes in lymphocyte protein synthesis and second messenger levels. Life Sci. 63:13–21.
Piantadosi, C. A. and Tatro, L. G. 1990. Regional H2O2 concentration in rat brain after hypertoxic convulsions. J. Appl. Physiol. 69:1761–1766.
Brunn, L., Hlgdall, E. V., Vuust, J., Houen, G. 1998. Polyaminestimulated binding of diamine oxidase to DNA. Acta. Chem. Scand. 52:921–929.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dahel, K.Ad., Al-Saffar, N.M. & Flayeh, K.A. Polyamine Oxidase Activity in Sera of Depressed and Schizophrenic Patients after ECT Treatment. Neurochem Res 26, 415–418 (2001). https://doi.org/10.1023/A:1010959300545
Issue Date:
DOI: https://doi.org/10.1023/A:1010959300545